CNSX:GTIIPharmaceuticals
A Look At Green Thumb Industries (CNSX:GTII) Valuation After Reshaping RYTHM Royalty Economics
Green Thumb Industries (CNSX:GTII) just reshaped its economics around RYTHM, moving from sales-based royalties to fixed annual cash fees that total US$70 million. This shift directly affects earnings visibility.
See our latest analysis for Green Thumb Industries.
The latest agreement news comes after a sharp short-term rebound, with a 7-day share price return of 21.25% and a 1-year total shareholder return of 35.85%. However, longer-term returns remain mixed and momentum has been uneven.
If...